Neuropace shares owned by Vanguard Group
Historical chart of Vanguard Group investment in Neuropace
Tip: Access up to 7 years of quarterly data
All positions including Neuropace held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neuropace by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $15M | 1.4M | 10.31 |
| 2025-06-30 | $15M | 1.4M | 11.14 |
| 2025-03-31 | $15M | 1.2M | 12.29 |
| 2024-12-31 | $12M | 1.1M | 11.19 |
| 2024-09-30 | $6.9M | 995k | 6.97 |
| 2024-06-30 | $7.3M | 968k | 7.56 |
| 2024-03-31 | $6.4M | 489k | 13.20 |
| 2023-12-31 | $4.3M | 413k | 10.31 |
| 2023-09-30 | $3.8M | 386k | 9.73 |
| 2023-06-30 | $1.7M | 378k | 4.49 |
| 2023-03-31 | $1.4M | 297k | 4.64 |
| 2022-12-31 | $408k | 274k | 1.49 |
| 2022-06-30 | $1.4M | 274k | 4.95 |
| 2022-03-31 | $2.6M | 311k | 8.21 |
| 2021-09-30 | $4.7M | 294k | 15.85 |
| 2021-06-30 | $6.9M | 292k | 23.78 |